The board of the Netherlands Heart Institute has appointed a programme committee to help shape the scientific content of the programme. The programme committee consists of:

Femke Onwezen and Jan Weijers of the Netherlands Heart Institute provide support for the programme committee.

Emma Robinson

I joined the lab of Prof Stephane Heymans in the Centre for Heart Failure Research at Maastricht University as a postdoctoral researcher in February 2018.
My training is in basic molecular biosciences. I recently obtained my PhD in Biological Sciences from the University of Cambridge (UK) and I have a Masters in Cellular and Molecular Biochemistry from Oxford University (UK). My research interests include understanding the molecular and epigenetic mechanisms underlying the pathophysiology of difficult-to-treat etiologies of heart failure.
I have additional affilitations with the Department of Cardiovascular Sciences at KU Leuven, Belgium and with the Genome Institute Singapore, Singapore.
Having attended the last two Translational Research meetings of the Netherlands Heart Institute – in 2017 as a visitor and in 2018 as a speaker – I am very pleased and excited to be part of the organization committee for 2019.

Back to the top

J. Wouter Jukema

J. Wouter Jukema, is professor of Cardiology, past Established Clinical Investigator at the Netherlands Heart Foundation and is Chairman of “Leiden Vascular Medicine” at Leiden University Medical Center (LUMC) in the Netherlands. He is also founding director of the Durrer Center for Cardiogenetic Research in Amsterdam.
He started his research with the Angiographic Coronary Atherosclerosis Trial REGRESS

His current interests, which comprise the majority of topics for his more than 1000 peer reviewed publications (with many in top journals like NEJM, Lancet, Science, Nature, Circulation, JACC and EHJ) focus on the field of athero-thrombosis and include interventional cardiology as well as atherosclerosis research (vascular biology, lipid modification, diabetes, anti-thrombotics/anti-platelets and genetics) in humans as well as in transgenic animals.

Prof. Jukema is principal investigator in several large interventional/athero-thrombosis studies, a member of various (inter)national athero-thrombosis boards and is holder of multiple (a.o. EU) grants.

Back to the top

Niels Riksen

Niels Riksen is a full professor of Vascular Medicine at the Radboud university medical center in Nijmegen. After a PhD in 2007 on clinical pharmacology and ischemia-reperfusion injury and a postdoc period in the Hatter Cardiovascular Institute in London on myocardial ischemia-reperfusion injury, he was registered as an internist and specialist in vascular medicine in 2010 and became head of department of vascular medicine of the Radboud university medical center in 2012.

In 2012, with a dr. Dekker grant from the Netherlands Heart Foundation, his research focus shifted towards the role of innate immune cells, in particular innate immune memory, in atherosclerosis. In recent years he published several papers on this topic in Cell, Cell Metabolism, Circulation, and the European Heart Journal.

Back to the top